Advertisement

A Biomedical Shortcut to (Fraudulent) Happiness? An Analysis of the Notions of Well-Being and Authenticity Underlying Objections to Mood Enhancement

  • Birgit BeckEmail author
  • Barbara Stroop
Chapter
Part of the Happiness Studies Book Series book series (HAPS)

Abstract

The increasing administration of so-called ‘mood enhancers’ such as antidepressants which are taken for non-therapeutic purposes in order to promote feelings ‘better than well’ has stimulated a bioethical debate on the moral and legal permissibility of their use. In these discussions it is pointed out that people are likely to view mood enhancing technologies as a useful means for directly increasing their well-being with lesser effort compared to traditional means—as a ‘biomedical shortcut’ to happiness. However, this view has received fierce criticism. Opponents of mood enhancement such as the President’s Council on Bioethics argue that there is a danger of a ‘fraudulent happiness’. This paper provides an attempt to disentangle various presumptions underlying the charge in order to analyze whether mood enhancement inevitably leads to ‘fraudulent happiness’. Thereby, it focuses primarily on the examination of two concepts, namely the notions of well-being and authenticity. The results of the analysis illustrate that giving credibility to the charge requires the assumption of specific notions of well-being and authenticity, which are not the only ones possible. When reflecting upon the assertion from a new perspective this article closes by concluding that mood enhancement does not inevitably lead to fraudulent happiness.

Keywords

Mood enhancement Fraudulent happiness Well-Being and authenticity Notions of well-being Promoting feelings Pharmacological road to happiness 

References

  1. Bayertz, K. (2005). Die menschliche Natur. Welchen und wieviel Wert hat sie? Paderborn: mentis.Google Scholar
  2. Bayertz, K., Beck, B., & Stroop, B. (2012). Künstliches Glück? Biotechnisches Enhancement als (vermeintliche) Abkürzung zum guten Leben. Philosophischer Literaturanzeiger, 65(4), 339–376.CrossRefGoogle Scholar
  3. Berghmans, R., ter Meulen, R., Malizia, A., & Vos, R. (2011). Scientific, ethical, and social issues in mood enhancement. In J. Savulescu, R. ter Meulen & G. Kahane (Eds.), Enhancing human capacities (pp. 153–165). Chichester: Wiley-Blackwell.Google Scholar
  4. Birnbacher, D. (2006). Natürlichkeit. Berlin: de Gruyter.CrossRefGoogle Scholar
  5. Bolt, L. L. E. (2007). True to oneself? Broad and narrow ideas on authenticity in the enhancement debate. Theoretical Medicine and Bioethics, 28(4), 285–300.CrossRefGoogle Scholar
  6. Bostrom, N., & Roache, R. (2007). Ethical issues in human enhancement. In J. Ryberg, T. S. Petersen & C. Wolf (Eds.), New waves in applied ethics (pp. 120–152). Basingstoke: Palgrave Macmillan.Google Scholar
  7. Brey, P. (2012). Well-being in philosophy, psychology and economics. In P. Brey, A. Briggle & E. Spence (Eds.), The good life in a technological age (pp. 15–34). New York: Routledge.Google Scholar
  8. Brülde, B. (2007). Can successful mood enhancement make us less happy? Philosophica, 79, 39–56.Google Scholar
  9. Bublitz, J. C., & Merkel, R. (2009). Autonomy and authenticity of enhanced personality traits. Bioethics, 23(6), 360–374.CrossRefGoogle Scholar
  10. Chatterjee, A. (2004). Cosmetic neurology. The controversy over enhancing movement, mentation, and mood. Neurology, 63(6), 968–974.CrossRefGoogle Scholar
  11. Cole-Turner, R. (1998). Do means matter? In E. Parens (Ed.), Enhancing human traits. Ethical and social implications (pp. 151–161). Washington, DC: Georgetown University Press.Google Scholar
  12. Crisp, R. (2008). Well-being. In E. N. Zalta (Ed.), The stanford encyclopedia of philosophy (Winter 2008 ed.,). URL = http://plato.stanford.edu/archives/win2008/entries/well-being/.
  13. Daniels, N. (1985). Just health care. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  14. DeGrazia, D. (2005a). Enhancement technologies and human identity. Journal of Medicine and Philosophy, 30, 261–283.CrossRefGoogle Scholar
  15. DeGrazia, D. (2005b). Human identity and bioethics. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  16. Elliott, C. (2003). Better than well. American medicine meets the American dream. New York: Norton.Google Scholar
  17. Feldmann, F. (2004). Pleasure and the good life: Concerning the nature, varieties, and plausibility of hedonism. Oxford: Oxford University Press.Google Scholar
  18. Finnis, J. (1980). Natural law and natural rights. Oxford: Clarendon Press.Google Scholar
  19. Galert, T. (2009). Wie mag Neuro-Enhancement Personen verändern? In B. Schöne-Seifert, D. Talbot, U. Opolka & J. S. Ach (Eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen (pp. 159–187). Paderborn: mentis.Google Scholar
  20. Griffin, J. (1986). Well-being. Its meaning, measurement, and moral importance. Oxford: Clarendon Press.Google Scholar
  21. Griffin, J. (1991). Against the taste model. In J. Elster & J. Roemer (Eds.), Interpersonal comparisons of well-being (pp. 45–69). Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  22. Guignon, C. (2004). On being authentic. London: Routledge.Google Scholar
  23. Heilinger, J. C. (2010). Anthropologie und Ethik des Enhancements. Berlin: de Gruyter.CrossRefGoogle Scholar
  24. Hildt, E. (2012). Neuroethik. München: Reinhardt.Google Scholar
  25. Juengst, E. T. (1998). What does enhancement mean? In E. Parens (Ed.), Enhancing human traits. Ethical and social implications (pp. 29–47). Washington, DC: Georgetown University Press.Google Scholar
  26. Kahane, G. (2011). Reasons to feel, reasons to take pills. In J. Savulescu, R. ter Meulen & G. Kahane (Eds.), Enhancing human capacities (pp. 166–178). Chichester: Wiley-Blackwell.Google Scholar
  27. Kramer, P. (1997). Listening to prozac. New York: Penguin Books.Google Scholar
  28. Kramer, P. (2000). The valorization of sadness. Alienation and the melancholic temperament. Hastings Center Report, 30(2), 13–18.CrossRefGoogle Scholar
  29. Krämer, F. (2009). Neuro-Enhancement von Emotionen. Zum Begriff emotionaler Authentizität. In B. Schöne-Seifert, D. Talbot, U. Opolka & J. S. Ach (Eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen (pp. 189–217). Paderborn: mentis.Google Scholar
  30. Krämer, F. (2011). Authenticity anyone? The enhancement of emotions via neuro-psychopharmacology. Neuroethics, 4(1), 51–64.CrossRefGoogle Scholar
  31. Levy, N. (2011). Enhancing authenticity. Journal of Applied Philosophy, 28(3), 308–318.CrossRefGoogle Scholar
  32. Liao, S. M., & Roache, R. (2011). After Prozac. In J. Savulescu, R. ter Meulen & G. Kahane (Eds.), Enhancing human capacities (pp. 245–256). Chichester: Wiley-Blackwell.Google Scholar
  33. McMillan, J. (2010). Prozac, authenticity and the aristotelian mean. In M. Häyry, T. Takala, P. Herissone-Kelly & G. Árnason (Eds.), Arguments and analysis in bioethics (pp. 185–196). Amsterdam/New York: Rodopi.Google Scholar
  34. Merkel, R., Boer, G., Fegert, J., Galert, T., Hartmann, D., Nuttin, B., et al. (2007). Intervening in the brain. Changing psyche and society. Berlin: Springer.Google Scholar
  35. Merkel, R. (2009). Mind doping? Eingriffe ins Gehirn zur „Verbesserung“ des Menschen: Normative Grundlagen und Grenzen. In N. Knoepffler & J. Savulescu (Eds.), Der neue Mensch? Enhancement und Genetik (pp. 177–212). Freiburg/München: Alber.Google Scholar
  36. Nagel, S. (2010). Ethics and the neurosciences. Ethical and social consequences of neuroscientific progress. Paderborn: mentis.Google Scholar
  37. Noggle, R. (2005). Autonomy and the paradox of self-creation: Infinite regresses, finite selves, and the limits of authenticity. In J. S. Taylor (Ed.), Personal autonomy. New essays on personal autonomy and its role in contemporary moral philosophy (pp. 87–108). Cambridge: Cambridge University Press.Google Scholar
  38. Nozick, R. (1974). Anarchy, state, and Utopia. New York: Basic Books.Google Scholar
  39. Nozick, R. (2006). The examined life. Philosophical meditations. New York: Simon & Schuster paperback edition.Google Scholar
  40. Parens, E. (2005). Authenticity and ambivalence: Towards understanding the enhancement debate. Hastings Center Report, 35(3), 34–41.CrossRefGoogle Scholar
  41. Parfit, D. (1987). Reasons and persons. Oxford: Clarendon Press.Google Scholar
  42. President’s Council on Bioethics. (2003). Beyond therapy. Biotechnology and the pursuit of happiness. New York: HarperCollins.Google Scholar
  43. Quante, M. (2013). Being identical by being (treated as) responsible. In M. Kühler & N. Jelinek (Eds.), Autonomy and the self (pp. 253–271). Dordrecht: Springer.CrossRefGoogle Scholar
  44. Savulescu, J., Sandberg, A., & Kahane, G. (2011). Well-being and enhancement. In J. Savulescu, R. ter Meulen & G. Kahane (Eds.), Enhancing human capacities (pp. 3–18). Chichester: Wiley-Blackwell.CrossRefGoogle Scholar
  45. Schermer, M. (2009). Changes in the self: The need for conceptual research next to empirical research. The American Journal of Bioethics—Neuroscience, 9(5), 45–47.CrossRefGoogle Scholar
  46. Schermer, M. (2013). Health, happiness, and human enhancement—dealing with unexpected effects of deep brain stimulation. Neuroethics, 6, 435–445.CrossRefGoogle Scholar
  47. Schleim, S. (2011). Glück in der Psychopharmakologie. Affektives und kognitives Enhancement. In D. Thomä, C. Henning & O. Mitscherlich-Schönherr (Eds.), Glück. Ein interdisziplinäres Handbuch (pp. 383–387). Stuttgart: Metzler.Google Scholar
  48. Schöne-Seifert, B. (2006). Pillen-Glück statt Psycho-Arbeit. Was wäre dagegen einzuwenden? In J. S. Ach & A. Pollmann (Eds.), No body is perfect (pp. 279–291). Bielefeld: transcript.Google Scholar
  49. Schöne-Seifert, B. (2009). Neuro-Enhancement: Zündstoff für tiefgehende Kontroversen. In B. Schöne-Seifert, D. Talbot, U. Opolka & J. S. Ach (Eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen (pp. 347–363). Paderborn: mentis.Google Scholar
  50. Schramme, T. (2008). Wohlergehen, individuelles. In S. Gosepath, W. Hinsch & B. Rössler (Eds.), Handbuch der politischen Philosophie und Sozialphilosophie (Vol. 2, pp. 1500–1504). Berlin: de Gruyter.Google Scholar
  51. Stephan, A. (2003). Zur Natur künstlicher Gefühle. In A. Stephan & H. Walter (Eds.), Natur und Theorie der Emotion (pp. 309–326). Paderborn: mentis.Google Scholar
  52. Sumner, L. W. (1996). Welfare, happiness, and ethics. Oxford: Clarendon Press.Google Scholar
  53. Synofzik, M. (2009). Psychopharmakologisches Enhancement: Ethische Kriterien jenseits der Treatment-Enhancement-Unterscheidung. In B. Schöne-Seifert, D. Talbot, U. Opolka & J. S. Ach (Eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen (pp. 49–68). Paderborn: mentis.Google Scholar
  54. Talbot, D. (2009). Ist Neuro-Enhancement keine ärztliche Angelegenheit? In B. Schöne-Seifert, D. Talbot, U. Opolka & J. S. Ach (Eds.), Neuro-Enhancement. Ethik vor neuen Herausforderungen (pp. 321–345). Paderborn: mentis.Google Scholar
  55. Tännsjö, T. (1998). Hedonistic utilitarianism. Edinburgh: Edinburgh University Press.Google Scholar
  56. Taylor, C. (1991). The ethics of authenticity. Cambridge, Mass.: Harvard University Press.Google Scholar
  57. Tiberius, V. (2008). The reflective life. Living wisely with our limits. Oxford: Oxford University Press.Google Scholar
  58. Tiberius, V., & A. Plakias. (2010). Well-being. In J. M. Doris & The Moral Psychology Research Group (Eds.), The moral psychology handbook (pp. 401–431). Oxford: Oxford University Press.Google Scholar
  59. Wassermann, D., & Liao, S. M. (2008). Issues in the pharmacological induction of emotions. Journal of Applied Philosophy, 25(3), 178–192.CrossRefGoogle Scholar
  60. Wolf, S. (1997). Happiness and meaning: Two aspects of the good life. Social Philosophy and Policy Foundation, 14(1), 207–225.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.INM-8: Ethics in the NeurosciencesResearch Centre JülichJülichGermany
  2. 2.Center for Advanced Study in BioethicsUniversity of MünsterMünsterGermany

Personalised recommendations